Literature DB >> 26354569

Hemodialysis versus peritoneal dialysis, which is cost-effective?

Abdolamir Atapour1, Atefeh Eshaghian, Diana Taheri, Shahaboddin Dolatkhah.   

Abstract

There is an increasing need for renal replacement therapy due to the growing number of cases with chronic kidney disease leading to end-stage renal disease. Two modalities of dialysis available are hemodialysis (HD) and peritoneal dialysis (PD). In this study, we aimed to compare the financial aspects of HD with PD. A total of 53 patients on HD and 43 patients on PD were included in the study and were assessed for several financial aspects of dialysis. The data collected were analyzed using SPSS-18. A statistically significant difference was noted between the HD and PD groups in the need for diagnostic tests, drugs, hospitalization, etc, with PD being less expensive. We strongly suggest physicians in our area to use PD on a larger number of patients for better financial outcome.

Entities:  

Mesh:

Year:  2015        PMID: 26354569     DOI: 10.4103/1319-2442.164578

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  4 in total

1.  Outcomes of peritoneal dialysis catheter configurations and pelvic fixation.

Authors:  Yash K Pandya; Jason K Wagner; Theodore Yuo; Mohammad Eslami; Michael J Singh; Eric S Hager
Journal:  Surg Open Sci       Date:  2019-05-18

2.  Characterization and proteomic profile of extracellular vesicles from peritoneal dialysis efflux.

Authors:  Laura Carreras-Planella; Jordi Soler-Majoral; Cristina Rubio-Esteve; Sara Inés Lozano-Ramos; Marcella Franquesa; Josep Bonet; Maria Isabel Troya-Saborido; Francesc Enric Borràs
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

3.  Economic Burden and Medical Insurance Impact of the Different Dialysis for End-stage Renal Diseases.

Authors:  Dan Gao; Sanhui Jing; Jian Wu; Ge Wu
Journal:  Iran J Public Health       Date:  2018-11       Impact factor: 1.429

4.  Non-medical facilitators and barriers towards accessing haemodialysis services: an exploration of ethical challenges.

Authors:  Godwin Pancras; Judith Shayo; Amani Anaeli
Journal:  BMC Nephrol       Date:  2018-12-03       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.